(+) - sattabacin 对水痘带状疱疹病毒的抗病毒活性。
Antiviral activity of (+)-sattabacin against varicella zoster.
机构信息
Department of Biology, Fort Lewis College, 1000 Rim Drive, Durango, CO 81301, USA.
出版信息
Bioorg Med Chem Lett. 2013 Jan 15;23(2):562-4. doi: 10.1016/j.bmcl.2012.11.017. Epub 2012 Nov 16.
Abstract
The first report of the antiviral activity of (+)-sattabacin against varicella-zoster virus (VZV) is described. Our results show that (+)-sattabacin potently inhibits the growth of VZV at concentrations in the range of other drugs commonly prescribed for VZV infection. Experiments detailing the synthesis of (+)-sattabacin, quantification of cytotoxicity and gene expression data in human fibroblast cells are also presented. Gene expression data was obtained through microarray analysis from human fibroblast cells exposed to sattabacin in order to identify a possible mechanism by which (+)-sattabacin inhibits VZV replication.
摘要
首次报道了 (+)-sattabacin 对水痘带状疱疹病毒 (VZV) 的抗病毒活性。我们的结果表明，(+)-sattabacin 能够在与其他常用于治疗 VZV 感染的药物相当的浓度范围内强力抑制 VZV 的生长。本文还详细介绍了 (+)-sattabacin 的合成、人成纤维细胞细胞的细胞毒性定量和基因表达数据。通过对暴露于 sattabacin 的人成纤维细胞进行微阵列分析获得了基因表达数据，以确定 (+)-sattabacin 抑制 VZV 复制的可能机制。
相似文献
1
Antiviral activity of (+)-sattabacin against varicella zoster.(+) - sattabacin 对水痘带状疱疹病毒的抗病毒活性。
Bioorg Med Chem Lett. 2013 Jan 15;23(2):562-4. doi: 10.1016/j.bmcl.2012.11.017. Epub 2012 Nov 16.
2
Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor.一种基于吲哚的衍生物作为强效且选择性水痘带状疱疹病毒（VZV）抑制剂的鉴定。
Eur J Med Chem. 2016 Nov 29;124:773-781. doi: 10.1016/j.ejmech.2016.09.014. Epub 2016 Sep 7.
3
Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.超深度测序在检测水痘-带状疱疹病毒抗病毒耐药突变中的应用。
Antiviral Res. 2018 Mar;151:20-23. doi: 10.1016/j.antiviral.2018.01.008. Epub 2018 Jan 12.
4
Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.6-或8-取代基对3-芳基烷基硫代甲基咪唑并[1,2-a]吡啶抗人巨细胞病毒（CMV）和水痘带状疱疹病毒（VZV）活性的影响：第二部分。
Bioorg Med Chem. 2008 Nov 1;16(21):9536-45. doi: 10.1016/j.bmc.2008.09.027. Epub 2008 Sep 13.
5
Antiviral activity of oxetanocins against varicella-zoster virus.氧杂环丁烷类化合物对水痘-带状疱疹病毒的抗病毒活性。
Antimicrob Agents Chemother. 1991 Jul;35(7):1512-4. doi: 10.1128/AAC.35.7.1512.
6
Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.一类新型高特异性抗水痘带状疱疹病毒双环嘧啶核苷对水痘带状疱疹病毒的化疗
Biochim Biophys Acta. 2002 Jul 18;1587(2-3):287-95. doi: 10.1016/s0925-4439(02)00091-1.
7
Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV).6位或8位取代对3-苯乙基硫甲基咪唑并[1,2-a]吡啶抗人巨细胞病毒（HCMV）和水痘带状疱疹病毒（VZV）活性的影响。
Bioorg Med Chem. 2007 Nov 15;15(22):7209-19. doi: 10.1016/j.bmc.2007.03.061. Epub 2007 Mar 24.
8
Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro.甘草酸对水痘-带状疱疹病毒的体外抗病毒活性。
Antiviral Res. 1987 Feb;7(2):99-107. doi: 10.1016/0166-3542(87)90025-8.
9
Sattabacins and sattazolins: new biologically active compounds with antiviral properties extracted from a Bacillus sp.
J Antibiot (Tokyo). 1995 Sep;48(9):967-72. doi: 10.7164/antibiotics.48.967.
10
Dihydropyrimidinone/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation.二氢嘧啶酮/1,2,3-三唑杂合分子的合成及抗水痘带状疱疹病毒（VZV）活性评价。
Eur J Med Chem. 2018 Jul 15;155:772-781. doi: 10.1016/j.ejmech.2018.06.028. Epub 2018 Jun 13.
引用本文的文献
1
Chemoenzymatic Synthesis of Indole-Containing Acyloin Derivatives.吲哚含酰基醇衍生物的酶促合成。
Molecules. 2023 Jan 1;28(1):354. doi: 10.3390/molecules28010354.
2
Isolation and identification of a male-produced aggregation-sex pheromone for the velvet longhorned beetle, Trichoferus campestris.雄性聚集信息素的分离与鉴定——以草地贪夜蛾为例。
Sci Rep. 2019 Mar 14;9(1):4459. doi: 10.1038/s41598-019-41047-x.
3
Anti-Pigmentary Effect of (-)-4-Hydroxysattabacin from the Marine-Derived Bacterium Bacillus sp.海洋来源芽孢杆菌中(-)-4-羟基萨塔巴辛的抗色素沉着作用
Mar Drugs. 2017 May 13;15(5):138. doi: 10.3390/md15050138.
本文引用的文献
1
Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society.二十一世纪的美国老龄化：麦克阿瑟基金会老龄化社会研究网络的人口预测。
Milbank Q. 2009 Dec;87(4):842-62. doi: 10.1111/j.1468-0009.2009.00581.x.
2
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.水痘带状疱疹病毒感染：临床特征、疾病的分子发病机制及潜伏状态
Neurol Clin. 2008 Aug;26(3):675-97, viii. doi: 10.1016/j.ncl.2008.03.011.
3
Collaborative programs. Genome Consortium for Active Teaching (GCAT).合作项目。主动教学基因组联盟（GCAT）。
Science. 2006 Feb 24;311(5764):1103-4. doi: 10.1126/science.1121955.
4
Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.美国引入水痘疫苗后，儿童和成人与水痘相关的住院率和费用下降。
Pediatrics. 2004 Sep;114(3):786-92. doi: 10.1542/peds.2004-0012.
5
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity.用于评估哺乳动物细胞细胞毒性的阿拉玛蓝（刃天青）荧光染料的研究。
Eur J Biochem. 2000 Sep;267(17):5421-6. doi: 10.1046/j.1432-1327.2000.01606.x.
6
Antiviral agents for non-human immunodeficiency virus infections.用于非人类免疫缺陷病毒感染的抗病毒药物。
Mayo Clin Proc. 1999 Dec;74(12):1266-83. doi: 10.4065/74.12.1266.
7
Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.伐昔洛韦。对其在疱疹病毒感染中的抗病毒活性、药代动力学特性及治疗效果的综述。
Drugs. 1996 Nov;52(5):754-72. doi: 10.2165/00003495-199652050-00009.
8
Sattabacins and sattazolins: new biologically active compounds with antiviral properties extracted from a Bacillus sp.
J Antibiot (Tokyo). 1995 Sep;48(9):967-72. doi: 10.7164/antibiotics.48.967.
9
Antiviral resistance in clinical practice.临床实践中的抗病毒耐药性。
Antiviral Res. 1995 Apr;26(4):423-38. doi: 10.1016/0166-3542(95)00031-g.
10
Elevation of the levels of SmB, B' and D proteins but not that of the La (SS-B) antigen during HSV infections.
J Autoimmun. 1989 Oct;2(5):701-8. doi: 10.1016/s0896-8411(89)80008-3.
Zotero 插件